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The effect of a pretreatment with Corynebacterium 
parvum (C. parvum) on contact allergy in BALB/c mice 
was studied. Mice sensitized with 50 ILl (supraoptimal 
dose) 2.4-dinitrofluorobenzene (DNFB, 0.5%) showed a 
suppressed response as measured by ear swelling after 
painting the right ear with 0.3. % DNFB in comparison to 
an allergic response obtained with an optimal sensitiza-
tion dose (15 ILl DNFB 0.5%). By transfer of spleen cells 
frOID donors sensitized with a supraoptimal or an opti-
m.al dose to recipients either challenged or sensitized 
shortly afterwards with DNFB it could be shown that 
less functionally active immune T-Iymphocytes of the 
delayed hypersensitivity type and significantly more 
suppressor T-cells were induced in supraoptimally sen-
s itized mice in comparison to the optimally sensitized 
aniInals. 
Intraperitoneal injection of C. parvum (2.8 mg/mouse) 
one week before sensitization enhanced the contact al-
lergic response in mice sensitized with a supraoptimal 
dose of DNFB, with little effect on the response in opti-
m.ally sensitized animals. Further analysis of this en-
hancement in transfer experiments showed that C. par-
vum selectively suppressed the generation and/or func-
tional expression ofT-suppressor cells and, probably by 
this mechanism, increased the number of functionally 
active T-immune lymphocytes. 
It is proposed that possibly by activation of the im-
m.une system C. parvum will suppress suppressor cells 
in contact allergy and by this mechanism might facilitate 
sensitization to the contact allergen. 
The induction phase of contact allergy is characterized by 
cell interactions between allergen presenting macrophages and 
T -Iy rnphocytes which recognize the allergen and/ or an allergen 
modified allo-antigen (la-antigen [lJ) . Such T-lymphocytes pro-
liferate and differentiate into delayed type hypersensitivity 
effector cells (TDH ), producing Iymphokines such as migration 
inhibition factor. Previous work indicates that suppressor cells 
are also generated under conditions of normal immunization 
[2,3]. The immune response that develops may then be consid-
ered as a result of a balance between effector and suppressor 
elem.ents [4]. The interaction between macrophages and T-
lym.phocytes in the induction phase of contact allergy may be 
influenced by the functional state of the interacting macro-
phages. It is known that macrophages activated by C. parvum 
produce a number of stimulating or suppressive factors which 
may affect lymphocyte proliferation [5,6J and the induction of 
cytotoxic cells [7]. We studied the effect of C. parvum, which is 
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a potent stimulator of macrophages, on regulatory mecha nisms 
in contact allergy. It will be shown that C. parvum enhances 
the immune response by inhibiting the generation and/ or func-
tional expression of suppressor T-cells (Ts) in contact allergy. 
MATERIALS AND METHODS 
Mice 
BALB/ c mice were purchased from the Zentralinstitut fur Versuchs-
tierzucht, Hannover, FRG, kept under conventional condi t ions and 
used at the age of 10-12 weeks. 
R eagents 
C. parvum. (7 mg/ ml lot Ca 761) heat- inactivated was obtained from 
Welcome Research Laborato ries, Beckenham, England. 2.4-dinitroflu o-
robenzene (DNFB) was obtained from Sigma Chemical Co., Miinchen 
mG. ' 
Sensitization and Elicitation of DNFB Contact Sensitivity 
Mice were sensitized as described by Miller and Claman [8] with 
0.5% DNFB in 4:1 acetone:olive oil. Of this solution 15 ILl was placed on 
the shaved a bdominal skin of the animals on day 0 and 1. The ear was 
painted on the dorsum with 20 /ll of 0.3% DNFB in 4:1 acetone:olive oil 
on day 5 and the ear thickness measured 24 hI' later . Ear thickness was 
quantitated by using an engineers micrometer and the thickness of the 
painted eal' was compared with the thickness of the untreated ear of 
the same animal. The increment in eal' t hickness is called ear swelling 
and is expressed in 10- 2 mm. The use of an engineers micrometer to 
quant itate contact allergy by increased ear swelling a llows remarkably 
accurate measurements to be made. The average ear thickness of 
untreated ears in 1075 mice was 24.9 ± 1.4 10-2 mm . The ear thickness 
of 137 sensitized mice a fter challenge was 49.1 ± 5.6 10- 2 mm, the ear 
swelling 24.3 ± 5.5 10- 2 mm. The average ear swelling in 127 unsensi-
tized mice after painting of the ear with 0.3% DNFB was 2.6 ± 2.1 10- 2 
mm. 
Preparation and Transfer of Spleen Cells 
Cell suspensions from the spleen were prepared by gently teasing 
the tissue through a 60 mash wire screen into Dulbecco's minimum 
essential medium (Dulbecco's MEM) supplemented with 10% fetal calf 
serum (FCS). The cells were washed twice and an osmo shock was 
performed to lyse contaminating erythrocytes. The cells were counted 
and dilu ted to a concentration of 2 x 10"/ml in Dulbecco's MEM 
supplemented with 10% FCS. The cells (0.5 ml, 1 x 108 spleen cells/ 
mouse) were injected immediately int ravenously (i.v.). Two hours after 
injection the mice were either painted on the ear wi th 0.3% DNFB 0 1' 
in some experiments sensitized wi th 0.5% DNFB as described above. 
Statistical analysis: Results are given as mean ± standard devia tion 
(SD) . All data were analyzed by an one-way analysis of variance 
followed by Scheffre's test for least significant difference. 
RESULTS 
In order to determine the optimal amount of DNFB to 
sensitize the mice and to elicit a contact reaction variable 
sensitization and challenge doses were used. We found that 
increasing the sensitization dose to 50 l.tI of an 0.5% DNFB 
solution resulted in a significantly diminished ear swelling com-
pared with the optimal sensitizat ion dose of 15 fll of an 0.5% 
DNFB solution (Fig 1) . In a number of experiments C. parvum 
was injected in increasing amounts intraperitoneally (i.p.) at 
the time of sensitization and various periods of time before. 
Injection of increasing amounts of C. parvum on day 0 (first 
day of sensitization) resulted in a proportional suppression of 
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FIG 1. Ear swelling (mean ± SD) of mice sensitized with 15 or 50 
III 0.5% DNFB. Five days after sensit ization the mice were challenged 
with 20 III 0.3% DNFB on the right ear, swelling measured a fter 24 and 
48 hr. Ear swelling afte r 48 hI' was not significantly different from the 
24 hI' value. Negative control: nonsens it ized mice, pain ted with 20 III 
0.3% DNFB on the righ t ear. 
contact allergy. However, injection of C. parvum one or more 
weeks before sensitization had no effect on the allergic response 
to DNFB if optimal amounts of DNFB were used for sensiti-
zation (Fig 2). In contrast, as shown in Fig 3, injection of C. 
parvum i.p. one week before sensitization with a supraoptimal 
amount of DNFB (50 ,ul, 0.5%) increased the ear swelling in 
relation to that obtained with an optimal sensit ization dose. C. 
parvum injected 3 weeks or-in a lower dose (0.7 mg/ mouse)-
one week before sensitization was also effective (results not 
shown). . 
The following experiments were designed to analyze the 
suppressing effect of a supraoptimal dose on the allergic contact 
reaction and the mechanism of th~ stimulatory effect of C. 
parvum on this suppressed reaction . In Fig 4 the results of 
experiments are shown by which effector lymphocytes were 
transferred to untreated recipients. Spleen cells of mice sensi-
tized with an optimal dose of DNFB (15 ILl) and of such 
sensitized with 'a supraoptimal amount of DNFB (50 ILl) were 
transferred to untreated recipients which were painted on the 
ear 2 hr later with 0.3% DNFB. As shown in Fig 4 mice 
sensit ized with 15 ILl of DNFB showed the usual ear swelling 
(group a). Transfer of 1 x 108 spleen cells from mice sensitized 
with 15 ILl (group a) to untreated recipients followed by chal-
lenge with DNFB resulted in a significant ear swelling (50:"'60% 
of the positive control, group b). Sensitization of mice with 50 
III of DNFB resulted in a significantly reduced 'response (group 
c); after transfer of spleen cells from these mice to untreated 
recipients almost no ear swelling was observed (group d). This 
experiment suggests that sufficient functionally active TOH to 
sensitize the recipient animals had not been transferred. In the 
following experiment (Fig 5) the effect of C. parvum on the 
induction of TDH determined by transfer experiments was in-
vestigated. A similar experiment was performed as described ' 
above, however, spleen cells from mice sensitized with a su-
praoptimal dose of 50 ILl DNFB, and pretreated with 2.8 mg C. 
parvum i.p. one week before sensitization were also transferred. 
As shown in Fig 5 transfer of spleen cells obtained from mice 
pretreated one week before sensitization with 50 ,ul DNFB with 
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FJG 2. Effect of C. parvum on contact allergic response (ear swelling) 
of opt ima l sensitized mice. BALB/c mice were injected i.p. wit h C. 
parvum (C.P.) at the t imes and wit h the doses indicated before sensi-
t ization. After sensitization by 2 daily applications of 15 III DNFB (0.5%) 
the righ t ear was painted with 20 III DNFB (0.3%) on day 5 a nd ear 
swelling (mean ± SD) quantitated 24 hI' later. 
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FIG 3. Effect of C. pa/'vum (Cp., 2.8 mg i.p.) injected i.p. 6 days 
before sensitization with 15 III OJ' 50 p.l DNFB 0.5%. a = mice sens itized 
with 15 III DNFB, b = mice sensitized with 15 III DNFB, pretreated 
with C. pa/,vum, C = mice sensitized with 50 III DNFB, d = mice 
sensit ized with 50 III DNFB, pretreated with C. parvum, e = negative 
control (C). Statistical analysis: group c decreased from a (p < 0.05) 
a nd group d increased over c (p < 0.05) . 
C. parvum resulted in sufficient functionally active TDH which 
were able to transfer contact allergy to untreated recipient 
(group d). 
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FIG 4. Transfer of effector spleen cells (s.c. , 1 x 10" cells/mouse) to 
untreated recipient mice from donors sensitized with 15 III or 50 II I 
DNFB 0.5% 6 days before transfer. The recipient animals were chal-
lenged 2 hr after transfer with 20 III 0.3% DNFB on the right ear. a == 
animals sensitized with 15 III DNFB (positive control) , b = transfer of 
s.c. from animals of group a, C = animals sensitized with 50 III DNFB, 
d = transfer of s.c. from animals of group c, e = negative control, tf = 
transfer. Statistical analysis: group c decreased from a (p < 0.05) and 
group d decreased from b (p < 0.05). 
The following experiments were designed to study the effect 
of C. paruum on suppressor cells in this model. Suppression of 
DNFB contact allergy is partly mediated by suppressor T-
lymphocytes as has been reported in a number of publications 
[9,10]. Suppressor lymphocytes can be demonstrated by trans-
fer of spleen cells from mice made tolerant to the contact 
allergen to untreated recipients, which are then sensitized with 
an optimal sensitization dose and challenged as described under 
methods. Injection of 1 x 108 spleen cells from mice sensitized 
with 15 ILl DNFB into untreated recipients which were then 
sensitized with an optimal amount of DNFB did not reduce the 
contact allergic response (Fig 6, group c). However, injection of 
1 X lOB spleen cells from mice sensitized with 50 ILl of DNFB 
into untreated recipients reduced the allergic response signifi -
cantly after sensitization and elicitation of contact allergy as 
usual (group d). Heat-killing of the cells (56°C, 45 min) elimi -
nated their suppressive potential (group e). However, suppres-
sion of the immune response after injection of spleen cells from 
supra optimal sensitized mice was reversed by pretreating the 
donor mice with C. paruum one week before sensitization with 
50 p.l DNFB (Fig 6, group O. The ear swelling in these mice was 
comparable to that found in the normal positive control (group 
a) . Injection of spleen cells from nonsensitized mice pretreated 
with c. paruum 14 days before had no stimulatory effect on the 
elicitation of contact allergy with 50 ILl DNFB (group g, compare 
with group b), indicating that transfer of C. par uum together 
with the spleen cells was not responsible for the stimulation 
observed in group f. 
DISCUSSION 
The experimental model used to study the effect of C. paruum 
on suppressor mechanisms in contact allergy to DNFB allows 
to induce preferentially an effector or a suppressor mechanism 
by varying the sensitization dose of the contact allergen applied 
to the skin. The transfer experiments demonstrated that the 
development and/or expression of TDH was suppressed in mice 
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FIG 5. Effect of C. paruum. treatment 0 11 effector cell transfer. 
Spleen cells (s.c., 1 X 10" cells/mouse) from donors sensitized with 50 
II I DNFB 0.5% and pretreated with saline or C. paruwn (2.8 mg/ mouse) 
6 days before sensitization were transferred to untreated recipients. 
The recipient animals were challenged 2 hI' later with 0.3% DNFB. a 
= sensitization with 15,.u DNFB (positive control) , b = transfer of s.c. 
from animals of group a; c = transfer of s.c. from animals sensitized 
with 50 III DNFB 6 days before transfer, d = transfer of s.c. from 
animals pretreated with C. paruum 6 days before sensitization with 50 
III DNFB; e = negative control (e), cp. = C. paruum. Statistical 
analysis: group c decreased from group b (p < 0.05) ; group d increased 
over group C (p < 0.05); and group d not different from group b. 
sensitized with 50 p.I DNFB (Fig 4) and that a suppressor 
mechanism had been induced which could be transferred with 
living spleen cells to untreated recipients (Fig 6). The result of 
this experiment (Fig 6) suggests that suppressor cells had been 
induced by sensitization with 50 ILl DNFB. Alternatively, cell-
bound antigen which is an excellent inducer of suppressor T-
cells, may have been transferred [8]. However, this last possi-
bility seems to be unlikely since " tolerance" in our model could 
only be transferred with living spleen cells, whereas heat-killed 
cells were not effective. Tolerance by DNP-modified cells 
however, can be induced efficiently with heat-killed cells [8]. It 
is therefore concluded that depending on the dose of the aller-
gen used, the activation of either TDwcells or Ts-cells is favored 
These findings are in agreement with the observations of Sy: 
Miller, and Claman [11], who have described and analyzed 
immune suppression induced with a high dose of DNFB (anti-
gen-overload). According to thei.r results, this suppression is 
mediated by a T -suppressor cell whose precursor is cyclophos-
phamide sensitive [12]. 
Pretreatment of the mice before sensitization with C. paruum 
had a twofold effect: (a) C. pa/'uum injected shortly before 
sensitization in a high dose suppressed an optimally induced 
allergic response. (b) C. paruum injected in a lower dose and 1-
3 weeks before sensitization enhanced a suppressed immune 
response obtained by applying 50 ILl DNFB. . 
This result suggests that both effector and suppressor mech-
anisms were affected by C. parUllm, however, the suppressor 
mechanism appeared to be more sensitive. The suppressive 
effect of a high dose C. paruum injected shortly before sensiti-
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FIG 6. Effect of C. paruum on the suppressive effect of spleen ce lls 
(s.c.) transferred from donors sensitized with 15 or 50 fil DNFB. After 
transfer of 1 x 108 s.c. the recipients were sensitized with 15 fil DNFB 
0.5% and challenged 5 days later. a = sensit ization with 15 fil DNFB; b 
= sensitization with 50 fil DNFB. Transfer of s.c. from donors (group c-
g); c = sensitized with 15 fil; d = sensitized with 50 fil; e = h eat-killed 
(h.k.) S.c. , donors sensitized with 50 fil; r = pretreated with C. parUllm 
(C.p., 2.8 mg/mouse) 6 days before sensitization with 50 fil ; g = treated 
with C. parUllm (2.8 mg/mouse) 14 days before s.c. transfer into animals 
sensit ized after transfer with 50 fil DNFB; h = negative control. Statis-
tical analysis: group b decreased from group a (p < 0.05); group d 
decreased from group c (p <:: 0.05); group e increased over group d (p 
< 0.05) ; group f increased over group d (p < 0.05); and group g no t 
different from group b. 
zation on the contact reaction in optimally sensitized mice has 
not further been analyzed, however, recent observations suggest 
that the T-effector cells are only marginally suppressed by C. 
parvum (Knop, unpublished observation). 
Pretreatment with C. parvum inhibited the development or 
function of T . (Fig 6) and increased, most likely by this mech-
anism, the number of functionally active TDl-1 cells (Fig 5) as 
shown in the transfer experiments (Fig 5). The nature of the 
suppressor cell, preferentially inhibited by C. parvum, has not 
been determined, however, the data of Sy, Miller, and Claman 
[11] show that it is a T-Iymphocyte. Furthermore, using another 
model of T . induction we were able to demonstrate that pre-
treatment of mice with C. parvum before injection of the 
tolerogen suppressed the induction of T "-cells (Knop, Riech-
mann ~nd Macher, to be published). Recently, a similar effect 
of BCG on suppressor T -cell activity on delayed-type hypersen-
sitivity to sheep red blood cells has been described [13]. 
The exact target of the suppressor cell inhibitory effect of C. 
parvum has to be determined. Various suppressor T -cells have 
been recognized in DNFB contact allergy. Twokinds ofT.-cells 
are induced by supraoptimal doses of epicutaneous DNFB, one 
which blocks the afferent (T.-aft), another one which blocks the 
efferent limb (T.-eft) of the immune response [12]. C. parvum 
may act on the precursor T .-cell, on the expression of the 
various T .-cells and their products such as soluble suppressor 
factor (SSF, [14]) . 
The mechanism of the inhibitory effect of C. parvum on T . is 
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unclear. It has been shown in several experimental models that 
C. parvum inj ected i.v. or i.p. induces suppressor macrophages 
which in tUJ'n suppress several lymphocytic responses such as 
the generation of cytotoxic lymphocytes [6] or Concanavalin A 
induced lymphocyte proliferation [5,6]. Activated macrophages 
produce a number of lymphocyte suppressive factors such as 
interferon [15], low molecular weight inhibi tors [16] a nd pros-
taglandins [17]. The effect of such macrophages on suppressor 
T-cells is of particular interest since little is known about such 
an interaction. However, C. parvum may a lso act on T- Iympho-
cytes as shown by Sljivic and Watson [18] or the C. paruum 
effect observed in our experiments may not be r elated to either 
cell. 
Finally, our results point to a possible patho-physiological 
role of an unspecifically activated immune system in contact 
allergy. This may suppress the damping mechanism which 
usually controls the immune response in contact allergy result-
ing in facilitation of a positive immune response to the contact 
allergen. 
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